CRISPR-Cas-based Techniques for Pathogen Detection: Retrospect, Recent Advances, and Future Perspectives
Overview
Authors
Affiliations
Background: Early detection of pathogen-associated diseases are critical for effective treatment. Rapid, specific, sensitive, and cost-effective diagnostic technologies continue to be challenging to develop. The current gold standard for pathogen detection, polymerase chain reaction technology, has limitations such as long operational cycles, high cost, and high technician and instrumentation requirements.
Aim Of Review: This review examines and highlights the technical advancements of CRISPR-Cas in pathogen detection and provides an outlook for future development, multi-application scenarios, and clinical translation.
Key Scientific Concepts Of Review: Approaches enabling clinical detection of pathogen nucleic acids that are highly sensitive, specific, cheap, and portable are necessary. CRISPR-Cas9 specificity in targeting nucleic acids and "collateral cleavage" activity of CRISPR-Cas12/Cas13/Cas14 show significant promise in nucleic acid detection technology. These methods have a high specificity, versatility, and rapid detection cycle. In this paper, CRISPR-Cas-based detection methods are discussed in depth. Although CRISPR-Cas-mediated pathogen diagnostic solutions face challenges, their powerful capabilities will pave the way for ideal diagnostic tools.
CRISPR in clinical diagnostics: bridging the gap between research and practice.
Lafi Z, Ata T, Asha S Bioanalysis. 2025; 17(4):281-290.
PMID: 39902531 PMC: 11866644. DOI: 10.1080/17576180.2025.2459520.
Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria.
Ma J, Lu Z Microorganisms. 2025; 13(1).
PMID: 39858940 PMC: 11767912. DOI: 10.3390/microorganisms13010172.
CRISPR/Cas system and its application in the diagnosis of animal infectious diseases.
Rasool H, Chen Q, Gong X, Zhou J FASEB J. 2024; 38(24):e70252.
PMID: 39726403 PMC: 11671863. DOI: 10.1096/fj.202401569R.
Xie S, Yue Y, Yang F Micromachines (Basel). 2024; 15(11).
PMID: 39597141 PMC: 11596558. DOI: 10.3390/mi15111329.
Chen Y, Wu J, Gao E, Lu Y, Qiu H J Med Microbiol. 2024; 73(10).
PMID: 39360804 PMC: 11448473. DOI: 10.1099/jmm.0.001892.